CY1124529T1 - Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινου - Google Patents
Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινουInfo
- Publication number
- CY1124529T1 CY1124529T1 CY20211100840T CY211100840T CY1124529T1 CY 1124529 T1 CY1124529 T1 CY 1124529T1 CY 20211100840 T CY20211100840 T CY 20211100840T CY 211100840 T CY211100840 T CY 211100840T CY 1124529 T1 CY1124529 T1 CY 1124529T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cancer
- treatment
- monomyleinimide
- functionalized
- gold compounds
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 150000002344 gold compounds Chemical class 0.000 title 1
- 239000010938 white gold Substances 0.000 title 1
- 229910000832 white gold Inorganic materials 0.000 title 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 abstract 1
- DVQHYTBCTGYNNN-UHFFFAOYSA-N azane;cyclobutane-1,1-dicarboxylic acid;platinum Chemical class N.N.[Pt].OC(=O)C1(C(O)=O)CCC1 DVQHYTBCTGYNNN-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003058 platinum compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με νέες λειτουργικοποιημένες με μονομηλεϊνιμίδιο ενώσεις λευκόχρυσου του τύπου (Ι), συμπεριλαμβανομένων ειδικότερα νέων λειτουργικοποιημένων με μονομηλεϊνιμίδιο παραγώγων οξαλιπλατίνας και καρβοπλατίνας, καθώς επίσης με τη χρήση τους ως φάρμακα, ειδικότερα για την αντιμετώπιση ή πρόληψη καρκίνου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15198739 | 2015-12-09 | ||
PCT/EP2016/080453 WO2017097986A1 (en) | 2015-12-09 | 2016-12-09 | Monomaleimide-functionalized platinum compounds for cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124529T1 true CY1124529T1 (el) | 2022-07-22 |
Family
ID=54849106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100840T CY1124529T1 (el) | 2015-12-09 | 2021-09-27 | Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινου |
Country Status (20)
Country | Link |
---|---|
US (2) | US10723748B2 (el) |
EP (1) | EP3386997B1 (el) |
JP (1) | JP6867652B2 (el) |
CN (1) | CN108368143B (el) |
AU (1) | AU2016367306B2 (el) |
CA (1) | CA3004630A1 (el) |
CY (1) | CY1124529T1 (el) |
DK (1) | DK3386997T3 (el) |
ES (1) | ES2898704T3 (el) |
HR (1) | HRP20211466T1 (el) |
HU (1) | HUE056897T2 (el) |
IL (1) | IL259864B (el) |
LT (1) | LT3386997T (el) |
MX (1) | MX2018006953A (el) |
PL (1) | PL3386997T3 (el) |
PT (1) | PT3386997T (el) |
RS (1) | RS62412B1 (el) |
SG (1) | SG11201804885TA (el) |
SI (1) | SI3386997T1 (el) |
WO (1) | WO2017097986A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101915452B1 (ko) * | 2014-06-23 | 2018-11-06 | 플라콘 테라퓨틱스 인코포레이티드 | 백금 화합물, 조성물 및 이의 용도 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
CN109171001A (zh) * | 2018-09-14 | 2019-01-11 | 上海烟草集团有限责任公司 | 草酸钠在降低卷烟烟气中TSNAs释放量中的应用 |
US20230339997A1 (en) * | 2020-09-11 | 2023-10-26 | Shanghai Haiju Biological Technology Co., Ltd. | Class of platinum compounds for treating cancer, and method for preparation thereof |
CN114539320A (zh) * | 2020-11-25 | 2022-05-27 | 北京大学 | 辐射激活的四价铂配合物及其用途 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
CH588505A5 (el) | 1972-06-08 | 1977-06-15 | Research Corp | |
US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
JPS607934A (ja) | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソ−ムの製造方法 |
HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
EP0142641B1 (de) | 1983-09-26 | 1991-01-16 | Udo Dr. Ehrenfeld | Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr |
EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
CS269719B1 (en) | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
DE19636889A1 (de) | 1996-09-11 | 1998-03-12 | Felix Dr Kratz | Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel |
EP1019023B1 (en) | 1997-09-29 | 2003-05-07 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
KR100508289B1 (ko) | 1998-04-21 | 2005-08-17 | 마이크로메트 에이지 | Cd19×cd3 특이 폴리펩티드 및 그의 용도 |
DE19926154A1 (de) | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung |
AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
EP1458360B1 (en) | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
DE10314780A1 (de) | 2003-03-19 | 2004-09-30 | Ktb Tumorforschungsgesellschaft Mbh | Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden |
RS20050714A (sr) | 2003-03-31 | 2008-04-04 | Pliva-Lachema A.S., | Farmaceutski preparati koji kao aktivnu suptancu sadrže kompleks platine i postupci za njihovo dobijanje |
CZ296169B6 (cs) | 2004-09-08 | 2006-01-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
CZ2004964A3 (cs) | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
US20060205810A1 (en) | 2004-11-24 | 2006-09-14 | Schering Corporation | Platinum therapeutic combinations |
CZ300424B6 (cs) | 2006-06-20 | 2009-05-13 | Pliva - Lachema A. S. | Farmaceutická kompozice pro perorální podání |
CZ300590B6 (cs) | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
CZ300120B6 (cs) | 2006-06-20 | 2009-02-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
IN2014CN04961A (el) | 2011-12-05 | 2015-09-18 | Igenica Biotherapeutics Inc | |
KR102057356B1 (ko) * | 2012-02-27 | 2019-12-18 | 아뮤닉스 파마슈티컬스, 인크. | Xten 콘주게이트 조성물 및 그의 제조 방법 |
CN105722847A (zh) * | 2013-10-08 | 2016-06-29 | 阿特莱斯遗传学有限公司 | 标记化合物和它们在测定中的用途 |
WO2015102922A1 (en) | 2013-12-31 | 2015-07-09 | Blend Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
KR101915452B1 (ko) | 2014-06-23 | 2018-11-06 | 플라콘 테라퓨틱스 인코포레이티드 | 백금 화합물, 조성물 및 이의 용도 |
US20180186823A1 (en) | 2015-06-23 | 2018-07-05 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
EP3313392B1 (en) | 2015-06-23 | 2020-09-16 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
EP3313527B1 (en) | 2015-06-29 | 2021-02-24 | Case Western Reserve University | Anticancer drug-containing plant virus particles |
CA2991973C (en) | 2015-07-12 | 2021-12-07 | Suzhou M-Conj Biotech Co., Ltd. | Bridge linkers for conjugation of a cell-binding molecule |
EP3464280B1 (en) | 2016-06-06 | 2021-10-06 | F. Hoffmann-La Roche AG | Silvestrol antibody-drug conjugates and methods of use |
CN109690315A (zh) | 2016-07-08 | 2019-04-26 | 豪夫迈·罗氏有限公司 | 人附睾蛋白4(he4)用于评估muc16阳性癌症治疗的响应性的用途 |
WO2018026742A1 (en) | 2016-08-01 | 2018-02-08 | Askgene Pharma Inc. | Novel antibody-albumin-drug conjugates (aadc) and methods for using them |
CN108164512B (zh) | 2017-12-27 | 2021-05-25 | 沈阳药科大学 | 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用 |
CN108187063B (zh) | 2018-01-09 | 2020-09-08 | 沈阳药科大学 | 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药 |
-
2016
- 2016-12-09 PL PL16822917T patent/PL3386997T3/pl unknown
- 2016-12-09 ES ES16822917T patent/ES2898704T3/es active Active
- 2016-12-09 MX MX2018006953A patent/MX2018006953A/es active IP Right Grant
- 2016-12-09 US US16/060,559 patent/US10723748B2/en active Active
- 2016-12-09 DK DK16822917.7T patent/DK3386997T3/da active
- 2016-12-09 JP JP2018529981A patent/JP6867652B2/ja active Active
- 2016-12-09 LT LTEPPCT/EP2016/080453T patent/LT3386997T/lt unknown
- 2016-12-09 WO PCT/EP2016/080453 patent/WO2017097986A1/en active Application Filing
- 2016-12-09 SG SG11201804885TA patent/SG11201804885TA/en unknown
- 2016-12-09 HR HRP20211466TT patent/HRP20211466T1/hr unknown
- 2016-12-09 SI SI201631342T patent/SI3386997T1/sl unknown
- 2016-12-09 AU AU2016367306A patent/AU2016367306B2/en active Active
- 2016-12-09 PT PT16822917T patent/PT3386997T/pt unknown
- 2016-12-09 IL IL259864A patent/IL259864B/en unknown
- 2016-12-09 RS RS20211187A patent/RS62412B1/sr unknown
- 2016-12-09 CA CA3004630A patent/CA3004630A1/en active Pending
- 2016-12-09 EP EP16822917.7A patent/EP3386997B1/en active Active
- 2016-12-09 CN CN201680072428.4A patent/CN108368143B/zh active Active
- 2016-12-09 HU HUE16822917A patent/HUE056897T2/hu unknown
-
2020
- 2020-06-17 US US16/904,528 patent/US11572379B2/en active Active
-
2021
- 2021-09-27 CY CY20211100840T patent/CY1124529T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20210002313A1 (en) | 2021-01-07 |
AU2016367306A1 (en) | 2018-06-14 |
JP2018538292A (ja) | 2018-12-27 |
US10723748B2 (en) | 2020-07-28 |
IL259864A (en) | 2018-07-31 |
AU2016367306B2 (en) | 2021-04-22 |
US11572379B2 (en) | 2023-02-07 |
LT3386997T (lt) | 2021-12-10 |
ES2898704T3 (es) | 2022-03-08 |
HRP20211466T1 (hr) | 2021-12-24 |
PT3386997T (pt) | 2021-11-04 |
CA3004630A1 (en) | 2017-06-15 |
SG11201804885TA (en) | 2018-07-30 |
IL259864B (en) | 2022-07-01 |
HUE056897T2 (hu) | 2022-03-28 |
RS62412B1 (sr) | 2021-10-29 |
CN108368143B (zh) | 2022-02-01 |
CN108368143A (zh) | 2018-08-03 |
PL3386997T3 (pl) | 2021-12-13 |
US20180354979A1 (en) | 2018-12-13 |
MX2018006953A (es) | 2019-05-16 |
EP3386997B1 (en) | 2021-06-30 |
WO2017097986A1 (en) | 2017-06-15 |
SI3386997T1 (sl) | 2021-11-30 |
JP6867652B2 (ja) | 2021-05-12 |
EP3386997A1 (en) | 2018-10-17 |
DK3386997T3 (da) | 2021-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124529T1 (el) | Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινου | |
CY1120969T1 (el) | Παραγωγα κινοξαλινης χρησιμα ως τροποποιητες fgfr κινασης | |
CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
CY1122186T1 (el) | Μεθοδοι θεραπειας καρκινου | |
CY1122966T1 (el) | 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου | |
CY1124726T1 (el) | Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv | |
CY1119110T1 (el) | Ρυθμιστες ρ2χ7 | |
CY1123417T1 (el) | Παραγωγα τετρα�δροϊσοκινολινης | |
CY1118744T1 (el) | Υποκατεστημενες τρικυκλικες ενωσεις ως αναστολεις fgfr | |
CY1119714T1 (el) | Ενωσεις αναστολεων | |
CY1122329T1 (el) | Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων | |
EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
EA201892802A1 (ru) | Производные аденозина для применения при лечении рака | |
CY1122243T1 (el) | Παραγωγα ν-πυριδiνυλικoυ ακεταμιδιου ως αναστολεις της οδου σηματοδοτησης wnt | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
CY1125150T1 (el) | Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου | |
CY1123263T1 (el) | Πολυκυκλικες ενωσεις ως αναστολεις κινασης τυροσινης bruton | |
EA201692091A1 (ru) | Хиноксалиновые соединения и их применение | |
CY1122441T1 (el) | Καινοτομες ενωσεις και συζευγματα κρυπτοφυκινης, η παρασκευη τους και η θεραπευτικη χρηση τους | |
EA201991196A1 (ru) | Претерпевшие самосборку диблок-сополимеры, состоящие из pegmema и несущих лекарственное средство полимерных сегментов | |
CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου |